Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up.
We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and biotech products.
Primary Care includes a broad spectrum of over-the-counter treatment solutions, prescription medications, supplements and medical devices. Our Biotech focuses on the development of treatments for rare diseases. The main therapeutic areas include pain relief, inflammation, ophthalmology, diabetes care, nutrition and oncology.
In the pursuit of improving human health, our R&D strives to break through in unconventional places. This is what led us to Nerve Growth Factor (NGF), a Nobel Prize-winning discovery made in 1986. We leveraged 50 years of research to transform this discovery into a breakthrough treatment. Our human recombinant NGF, cenegermin, is the first treatment for a rare degenerative eye disease, neurotrophic keratitis. That deep appreciation of science keeps us committed to investigating neurotrophins.
Our relentless pursuit in identifying new treatments for diseases allowed us to harness the potential of bioinformatics to accelerate the drug discovery process. The result is Exscalate, a structure-based virtual screening platform developed in-house and currently one of the most powerful supercomputing and artificial intelligence platforms for drug testing.
We are focused on the road ahead. Our hunger to deliver what patients need from science keeps us focused on what matters.
We embrace the challenge in science.
Company Details
- Employees
- 1.04K
- Address
- Via Santa Lucia, Milano,lombardia 20122,italy
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- dompe.com
- Keywords
- Pharmaceuticals, Biotechnology, Research and Development, Innovation, Primary Care, Self-medication products.
- HQ
- Milano, Lombardia
Dompé Questions
Dompé's website is dompe.com
Dompé's LinkedIn profile is https://www.linkedin.com/company/dompe
Dompé has
1.04K employees.
View email and phone details for 1.04K
employees at Dompé.
Dompé's industry is
Pharmaceutical Manufacturing
Dompé's top competitors are
Menarini Group,
Aboca,
Novartis Italia,
Alfasigma,
Zambon,
Chiesi Group,
Ibsa Italy,
Angelini Pharma,
Fidia Pharma,
Sanofi.
Dompé's categories are Pharmaceutical Manufacturing
